期刊文献+

Ⅱ型单胺囊泡转移体在SH-SY5Y细胞中的稳定表达

Stable Expression of Vesicular Monoamine Transporter 2 in SH-SY5Y Cells
下载PDF
导出
摘要 目的构建稳定表达Ⅱ型单胺囊泡转移体(VMAT2)的SH-SY5Y细胞系。方法构建VMAT2真核表达载体,利用脂质体转染神经母细胞瘤SH-SY5Y,选择筛选后挑取单克隆扩大培养,通过Western-blot及免疫荧光的方法鉴定蛋白质在细胞中的表达,并通过免疫双荧光技术对VMAT2在细胞系中的分布进行定位。结果Western-blot及免疫荧光结果显示该蛋白在挑选的细胞系中有高效表达。免疫双荧光结果显示表达的蛋白定位在大密度核心囊泡(LDCV)。结论该细胞系的成功构建为研究VMAT2在帕金森氏病(PD)发病机制中的作用奠定良好的基础。 Objective To establish the SH-SYSY cell line stably expressing vesicular monoamine transporter 2 (VMAT2). Methods An eukaryotic expression vector of VMAT2 was constructed and then transfected into SH-SYSY cells by Lipofectamine. The expression of VMAT2 in SH-SYSY cell line was detected by Western-blot and immunofluorescence technique. Double immunofluorescence technique was used to determine the localization of VMAT2 in the cells. Results VMAT2 was highly expressed in SH-SYSY cell line revealed by Western-blot and immunofluorescence and was found to locate on LDCV shown by double immunofluorescence technique. Conclusion This work has laid a good foundation for the further studies on the role of VMAT2 in Parkinson' s Disease ( PD).
出处 《中国比较医学杂志》 CAS 2005年第6期339-342,F0005,共5页 Chinese Journal of Comparative Medicine
关键词 Ⅱ型单胺囊泡转移体 SH-SY5Y VMAT2 SH-SY5Y
  • 相关文献

参考文献13

  • 1Schutz B,Schafer MK,Eiden LE,et.al.Vesicular amine transporter expression and isoform selection in developing brain,peripheral nervous system and gut [ J ].Brain Res Dev Brain Res1998,106(1-2):181-204.
  • 2Parsons SM.Transport mechanisms in acetylcholine and monoamine storage[J].FASEB J,2000,14(15):2423-2434.
  • 3Fon EA,Pothos EN,Sun BC,et.al.Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action[J].Neuron,1997,19(6):1271-1283.
  • 4Mooslehner KA,Chan PM,Xu W,et.al.Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood:potential mouse model for parkinsonism [J].Mol Cell Biol,2001,21(16):5321-5331.
  • 5Pothos EN,Larsen KE,Krantz DE,et al.Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size[J].J Neurosci,2000,20(19):7297-7306.
  • 6Harrington KA,Augood SJ,Kingsbury AE,etal.Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2)gene expression in the substantia nigra of control and Parkinson's disease [ J ].Brain Res Mol Brain Res,1996,36 (1):157-162.
  • 7Miller GW,Erickson JD,Perez JT,et al.Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease[J].Exp Neurol,1999,156(1):138-148.
  • 8Lee CS,Samii A,Sossi V,et al.In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease [ J ].Ann Neurol,2000,47(4),493-503.
  • 9Staal RG,Sonsalla PK.Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata[J].J Pharmacol Exp Ther,2000,293(2):336-342.
  • 10Goodall AR,Danks K,Walker JH,et.al.Occurrence of two types of secretory vesicles in the human neuroblastoma SH-SY5Y [ J].J Neurochem,1997,68(4):1542-1552.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部